Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells

Medicine and Dentistry

• Rapamycin 100%
• Tacrolimus 72%
• T Cell 36%
• Interferon 27%
• Interleukin 17 27%
• Cells 27%
• Regulatory T Cell 18%
• Combination Therapy 9%
• Tumor Necrosis Factor 9%
• In Vitro 9%
• Population 9%
• Interleukin 6 9%
• Interleukin 1 9%
• Cytokine 9%
• Mammalian Target of Rapamycin Inhibitor 9%
• Cell Population 9%
• Interleukin 2 9%
• Antigen Presenting Cell 9%
• Autoantigen 9%
• Winged Helix Transcription Factor 9%
• T Lymphocyte Subpopulation 9%
• T Cell Subset 9%
• Calcineurin 9%
• CD3 Antigen 9%
• Alloreactive T Cell 9%
• Culture 9%
• Assay 9%
• Differentiation 9%
• Donor 9%
• Aptitude 9%
• T-Helper Cell 9%

INIS

• interleukins 54%
• interferon 27%
• humans 18%
• inhibition 18%
• in vitro 9%
• information 9%
• populations 9%
• cytokines 9%
• additives 9%
• expansion 9%
• antigens 9%
• transcription factors 9%
• concentration 9%
• doses 9%
• proliferation 9%
• tumor necrosis factor 9%